Almoosa Health Company carries a market capitalization of 5.36B, placing it among publicly traded companies globally. Its enterprise value stands at 7.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.36B |
| Enterprise Value | 7.01B |
Almoosa Health Company currently has 44.30M shares outstanding.
| Shares Outstanding | 44.30M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Almoosa Health Company trades at a trailing price-to-earnings ratio of 29.26. The price-to-sales ratio is 4.24, and the price-to-book ratio stands at 7.23.
| PE Ratio | 29.26 |
| PS Ratio | 4.24 |
| PB Ratio | 7.23 |
| P/TBV Ratio | 3.18 |
| P/FCF Ratio | 7.34 |
| P/OCF Ratio | 31.74 |
On an enterprise value basis, Almoosa Health Company trades at an EV/EBITDA multiple of 36.50 and an EV/FCF ratio of 8.21. The EV/Sales ratio of 4.86 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 36.50 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.86 |
| EV / EBITDA | 36.50 |
| EV / EBIT | 36.50 |
| EV / FCF | 8.21 |
Almoosa Health Company maintains a current ratio of 1.71, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 50.19, indicating elevated leverage, while an interest coverage ratio of 9.08 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.71 |
| Quick Ratio | 0.14 |
| Debt / Equity | 50.19 |
| Debt / EBITDA | 5.05 |
| Interest Coverage | 9.08 |
Almoosa Health Company posts a return on equity of 25.06 and a return on invested capital of 6.80.
| Return on Equity (ROE) | 25.06 |
| Return on Assets (ROA) | 6.34 |
| Return on Invested Capital (ROIC) | 6.80 |
| Return on Capital Employed (ROCE) | 14.10 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 12.60 |
Over the trailing twelve months, Almoosa Health Company has paid 8.37M in income taxes, reflecting an effective tax rate of 3.85.
| Income Tax | 8.37M |
| Effective Tax Rate | 3.85 |
Almoosa Health Company's stock has declined approximately -24.61059% over the past 52 weeks. The 50-day moving average sits at 122.01, while the 200-day moving average is 152.41.
| Beta (5Y) | N/A |
| 52-Week Price Change | -24.61059% |
| 50-Day Moving Average | 122.01 |
| 200-Day Moving Average | 152.41 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Almoosa Health Company generated 1.44B in revenue and converted that into 208.93M in net income, yielding earnings per share of 4.72. EBITDA reached 192.01M, while operating income came in at 192.01M.
| Revenue | 1.44B |
| Gross Profit | 446.83M |
| Operating Income | 192.01M |
| Pretax Income | 217.30M |
| Net Income | 208.93M |
| EBITDA | 192.01M |
| EBIT | 192.01M |
| Earnings Per Share (EPS) | 4.72 |
Almoosa Health Company holds 75.53M in cash and equivalents against 970.50M in total debt, resulting in a net debt position of 849.93M. Total book value stands at 845.32M, with working capital of 370.51M providing operational flexibility.
| Cash & Cash Equivalents | 75.53M |
| Total Debt | 970.50M |
| Net Debt | 849.93M |
| Equity (Book Value) | 845.32M |
| Book Value Per Share | 19.11 |
| Working Capital | 370.51M |
Almoosa Health Company produced 192.56M in operating cash flow over the past twelve months. After subtracting -640.33M in capital expenditures, free cash flow totaled -447.78M - equivalent to -10.12 per share.
| Operating Cash Flow | 192.56M |
| Capital Expenditures | -640.33M |
| Free Cash Flow | -447.78M |
| FCF Per Share | -10.12 |
Almoosa Health Company operates with a gross margin of 31.00, reflecting its pricing power and cost economics. The operating margin of 13.32 and net profit margin of 14.49 provide insight into operational efficiency.
| Gross Margin | 31.00 |
| Operating Margin | 13.32 |
| Pretax Margin | 15.07 |
| Profit Margin | 14.49 |
| EBITDA Margin | 13.32 |
The company's payout ratio of 14.84 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.70 |
| Dividend Yield | N/A |
| Payout Ratio | 14.84 |
| Shareholder Yield | -2.94 |
| FCF Yield | 13.63 |
Almoosa Health Company posts an Altman Z-Score of 3.08, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.08 |